The covid-19 outbreak poses a challenge to the health systems of the affected countries. Both a high number of patient treatments and high throughput laboratory testing may suddenly become of urgent need. Automatic and fast CLIA solution is especially useful to investigate a high number of patients and identify the positive ones. It is also valuable in the diagnosis of secondary bacterial infection using PCT and CRP biomarkers for timely initiation of antibiotic treatment. Proinflammatory markers like interleukins or PCT may be employed in the early identification of severe disease complications like cytokine storm and ARDS. Monitoring of anti-SARS-CoV-2 antibodies is very beneficial in patients where neutralization antibody-containing plasma is to be applied as well as to evaluate immune response after vaccination and the vaccine efficacy validation.